THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS

Respiratory syncytial virus plays a significant role in etiology of respiratory infections in infants, and preterm children have muchhigher risk of severe course of the disease, than common population of children at the age less than 2 years old. Palivizumab is usedefficiently to prevent this infect...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Rudakova, I. V. Babachenko, V. B. Rovnyi, A. N. Uskov, Yu. V. Lobzin
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2012-07-01
Series:Вопросы современной педиатрии
Subjects:
children
respiratory syncytial virus
palivazumab
costs efficacy
Online Access:https://vsp.spr-journal.ru/jour/article/view/469
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items